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Abstract 
Introduction: Parasite recombinant proteins are gaining wide-spread attention due to its 
diagnostic application. This work aims at the evaluation of a novel fusion system for the 
production of a 12 kDa surface adherence protein from Cryptosporidium parvum, which has 
been reported as a potential target for cryptosporidiosis prevention and therapy [Yao et al, 
2006]. It is also intended to obtain specific antibodies and to study its ability to recognize the 
surface of sporozoites and oocysts.  
Methods: Specific primers were designed to amplify and sub-clone part of the gene that 
encodes for Cryptosporidium parvum 12kDa protein lacking its transmembrane domain. This 
truncated protein was expressed in E. coli using a novel fusion system that significantly 
increases protein production yields. After its purification by affinity chromatography on Ni-NTA 
columns, the protein was dialysed against phosphate buffer pH 8.0 and later injected in mice. 
The immune response obtained in mice was then evaluated by ELISA and immunofluorescence 
assays. 
Results: The expression levels of fused protein in E. coli increased about three folds when 
compared to the respective non-fused protein levels Results from ELISA and 
immunofluorescence assays confirmed the potential diagnostic interest of this recombinant 
antigen. 
Conclusions: Results from this work may provide an important advance on diagnostic and 
therapeutic field on cryptosporidiosis. 
 
